0001140361-23-050617.txt : 20231101
0001140361-23-050617.hdr.sgml : 20231101
20231101061529
ACCESSION NUMBER: 0001140361-23-050617
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231031
FILED AS OF DATE: 20231101
DATE AS OF CHANGE: 20231101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chen Ruoyu
CENTRAL INDEX KEY: 0001982080
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51173
FILM NUMBER: 231366446
MAIL ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GYRE THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001124105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562020050
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 650-266-8674
MAIL ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST BIOSCIENCES, INC.
DATE OF NAME CHANGE: 20150820
FORMER COMPANY:
FORMER CONFORMED NAME: TARGACEPT INC
DATE OF NAME CHANGE: 20000919
4
1
form4.xml
X0508
4
2023-10-31
0001124105
GYRE THERAPEUTICS, INC.
GYRE
0001982080
Chen Ruoyu
C/O GYRE THERAPEUTICS, INC.
12730 HIGH BLUFF DRIVE, SUITE 250
SAN DIEGO
CA
92130
true
Interim CFO
false
Stock Option (Right to Buy)
6.93
2023-10-31
4
A
0
34380
0
A
2033-10-31
Common Stock
34380
34380
D
These options are vested in full.
/s/ Ruoyu Chen
2023-11-01